SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Concern about staged IPO share unlocks and insider selling is weighing on Cerebras, alongside reports that OpenAIs latest ultrafast model runs on Nvidia GPUs rather than Cerebras hardware. Bulls debate the significance, citing Cerebras inference technology and other customer deals, while skeptics focus on potential selling pressure and the companys OpenAI exposure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume rally without a confirmed company announcement is driving attention, with traders debating whether institutional buying and short covering are behind the move or whether it could fade without news. Bulls also point to Anktivas growth and anticipated FDA label-expansion decision as potential catalysts, while speculation about leaked news remains unconfirmed.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

A reported federal loan to fund upgrades and expand capacity at three Vistra nuclear plants is drawing attention, against a backdrop of rising electricity demand from data centers. Traders largely view the proposal as bullish for Vistras nuclear and power-demand outlook, though some question why the share price remains volatile and whether the financing is as positive as hoped.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

A cluster of GameStop insider purchases, including Ryan Cohen and director Nat Turner, is driving attention. Bullish traders see the buying as a confidence signal and potential squeeze catalyst, while skeptics say it has not translated into sustained gains and want more concrete business news; some also point to potential dilution from warrants.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths shareholder-approved business combination with Armada II and its planned Nasdaq debut as an XRP-treasury company are driving a sharp speculative rally. Bulls focus on the anticipated XRP holdings and tight-float dynamics, while skeptics question the valuation relative to the XRP backing and warn of profit-taking and merger-related volatility.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MXLs sharp advance is drawing attention amid a broad semiconductor rally, with traders pointing to the jobs report and momentum buying rather than a confirmed company-specific catalyst. Bulls are celebrating the breakout, while others warn the move may be overextended and question whether it can hold its gains.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

Rising Treasury yields and expectations of persistently high rates are weighing on AGNC and other mortgage REITs, with traders pointing to pressure on mortgage-backed securities and the companys book value. Income-focused investors are buying the pullback for its monthly dividend, while others worry about further declines and possible dividend cuts.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares fell sharply after reports that Toshiba plans to double HDD capacity for AI data centers, raising concerns about future competition and pressure on WDCs pricing power. Many traders called the selloff an overreaction and bought the dip, citing strong AI-storage demand and the time Toshiba may need to scale, while others warned that added supply could weaken WDCs advantage.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

New RAMP 201 analyses for Verastems avutometinibdefactinib combination in recurrent low-grade serous ovarian cancer are drawing attention, with traders highlighting activity in KRAS wild-type patients and comparisons favoring the regimen over conventional care. Some see the findings as expanding the treatment opportunity, while others are frustrated by the muted share-price response and are looking ahead to the VS-7375 clinical update.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depots extended decline and repeated multi-year or 52-week lows dominate discussion, with traders linking the weakness to high mortgage rates and soft housing and renovation demand. Some see oversold levels as a buying opportunity, while others expect further downside until the housing backdrop improves.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

Precigen's Papzimeos and Ironwood's Linzess are driving growth, but competition, pipeline progress and single-product reliance shape each biotech's outlook.

Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?

Precigen's Papzimeos is gaining commercial momentum, while its pipeline potential through the AdenoVerse platform could create new growth opportunities.

Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?

PGEN's Papzimeos is driving strong early sales, while European expansion and pipeline progress could shape the stock's growth outlook.

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?

Papzimeos is fueling Precigen's growth, with sales more than doubling sequentially in Q2 and demand continuing to rise in 2026.

INOVIO to Participate in Upcoming Investor Conferences

INOVIO to Participate in Upcoming Investor Conferences INOVIO to Participate in Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Sept. 1, 2026 PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing...

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., Aug. 12, 2026 U.S. Food and Drug Administration (FDA) review of Biologics License Application...

 Bet on 5 Top-Ranked Stocks With Rising P/E 

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. 

INOVIO to Report Second Quarter Financial Results on August 12, 2026

INOVIO to Report Second Quarter Financial Results on August 12, 2026 INOVIO to Report Second Quarter Financial Results on August 12, 2026 PR Newswire PLYMOUTH MEETING, Pa., Aug. 4, 2026 PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on...

INOVIO Announces Pricing of $20.0 Million Public Offering

INOVIO Announces Pricing of $20.0 Million Public Offering INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on...

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29, 2026 PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Inovio Pharmaceuticals Inc

INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial  

Equity

Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

INO Inovio Pharmaceuticals Inc